MEDICAL PROPERTIES TRUST (MPT) CFO reports tax withholding on restricted stock

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

MEDICAL PROPERTIES TRUST INC Executive Vice President & CFO R. Steven Hamner reported a routine tax-related share disposition. On the vesting of restricted stock, 48,548 common shares were withheld at $4.67 per share to cover tax withholding obligations, which the company notes does not constitute a sale transaction. After this withholding, Hamner directly holds 3,841,020 shares of common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider HAMNER R STEVEN

Role Executive Vice President & CFO

Type	Security	Shares	Price	Value
Tax Withholding	Common stock, par value $0.001	48,548	$4.67	$227K

Holdings After Transaction: Common stock, par value $0.001 — 3,841,020 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Tax-withholding shares: 48,548 shares Withholding price: $4.67 per share Post-transaction holdings: 3,841,020 shares

3 metrics

Tax-withholding shares 48,548 shares Shares withheld upon restricted stock vesting for tax obligations

Withholding price $4.67 per share Price used for 48,548 withheld common shares

Post-transaction holdings 3,841,020 shares CFO’s direct common stock holdings after withholding

Key Terms

restricted stock, tax withholding obligations, Form 4, Executive Vice President & CFO, +1 more

5 terms

restricted stock financial

"Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

tax withholding obligations financial

"shares withheld upon vesting of restricted stock to satisfy tax withholding obligations"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Executive Vice President & CFO financial

"officer_title": "Executive Vice President & CFO""

Payment of exercise price or tax liability by delivering securities financial

"transaction_code_description": "Payment of exercise price or tax liability by delivering securities""

Form 4 Insider Transactions: What Each Field Means →

04/08/2026 - 08:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HAMNER R STEVEN

(Last)

(First)

(Middle)

10500 LIBERTY PARKWAY

(Street)

BIRMINGHAM

ALABAMA

35242

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MEDICAL PROPERTIES TRUST INC [ MPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive Vice President & CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock, par value $0.001	04/08/2026		F		48,548⁽¹⁾	D	$4.67	3,841,020	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

	W. Zachary Riddle, by power of attorney	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did MEDICAL PROPERTIES TRUST (MPT) CFO R. Steven Hamner report on this Form 4?

The filing shows 48,548 common shares were withheld upon vesting of restricted stock to satisfy tax withholding obligations. This is characterized as a tax-withholding disposition and is not considered an open-market sale or purchase of MEDICAL PROPERTIES TRUST shares.

Does the MEDICAL PROPERTIES TRUST (MPT) Form 4 indicate that the CFO sold shares in the open market?

No, the disclosure states the shares were withheld upon vesting of restricted stock to cover tax withholding obligations. The footnote explicitly clarifies this withholding does not constitute a sale transaction, distinguishing it from an open-market sale of MEDICAL PROPERTIES TRUST stock.

How many MEDICAL PROPERTIES TRUST (MPT) shares were involved in the CFO’s tax withholding event?

The Form 4 reports that 48,548 shares of common stock, par value $0.001, were withheld at $4.67 per share. These shares came from vested restricted stock and were used specifically to satisfy tax withholding obligations associated with that vesting event.

What is the MEDICAL PROPERTIES TRUST (MPT) CFO’s direct shareholding after this Form 4 transaction?

Following the tax-withholding disposition, Executive Vice President & CFO R. Steven Hamner directly holds 3,841,020 shares of common stock. This figure reflects his position after the 48,548 shares were withheld to meet tax obligations tied to restricted stock vesting.

What transaction code is used in MEDICAL PROPERTIES TRUST (MPT) CFO’s Form 4 and what does it mean?

The transaction is coded “F,” defined as payment of exercise price or tax liability by delivering securities. In this case, it represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations, and is not treated as a discretionary sale in the market.